mAb anti-Human PD-1 / CD279, 9B4

Description

Description: Mouse monoclonal antibody (mAb) to human programmed cell death-1 (PD-1), or mouse mAb to human CD279. 

Purification: Protein G affinity purified

Product Type: Primary antibody

Target Protein: Human programmed cell death-1 (PD-1)

Immunogen: 40kDa recombinant human programmed cell death-1 (PD-1) from ACRO Biosystems (Cat. No.: PD1-H5221).

Fusion Myeloma: Sp2/0-Ag14

Specificity: Reactive with human programmed cell death-1 (PD-1).

Species Reactivity: Human, others not tested.

Host / Isotype: Mouse, IgG1 Kappa

Formulation: Lyophilized from a solution in 0.01M PBS, pH 7.2

Reconstitution: Double distilled water is recommended to adjust the final concentration to 1.00mg/mL.

Storage: Store at -20^oC

Research Area: Immunosuppression

Background: 

Programmed Cell Death-1 (PD-1), also called CD279, is a 288 amino acid cell surface protein that belongs to the immunoglobulin superfamily.  The protein is expressed on T cells, B cells and macrophages.  When PD-1 is joined with its ligand (CD274 or B7-H1), the immune cell’s activation and effector function are attenuated.  Research suggested that PD1 pathway is mainly involved with attenuation at periphery sites while the B7/CTLA-4 pathway is primarily involved with the attenuation of the activation of immune cells in secondary lymphoid organs.  PD-1 pathway is implicated with cancer’s immune-evasion, autoimmunity, and Listeria monocytogenes infection.

Application:

1. Indirect ELISA: The antibody is reactive to recombinant human programmed cell death-1 (PD-1).

2. IHC (see image):  This antibody reacts with thymus gland section.  The sections were treated by heat induced epitope retrieval before primary antibody (20μg/mL) was added.  The secondary antibody was an HRP-labelled goat anti-mouse IgG antibody. 

References:

If research is published using this product, please inform Anogen in order to cite the reference on this datasheet. Anogen will provide one unit of product in the same category as gratitude.